Laboratory testing for cryoglobulins

American Journal of Hematology

Volumn 86, Issue 6, 2011, Pages 500-502

  Motyckova, Gabriela ^a,b   Murali, Mandakolathur ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CRYOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB;

ARTHRALGIA; ARTICLE; CRYOGLOBULINEMIA; FALSE NEGATIVE RESULT; HEMATOLOGIC DISEASE; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNODIFFUSION; INFECTION; LABORATORY TEST; MONOCLONAL IMMUNOGLOBULINEMIA; PLASMAPHERESIS; PRIORITY JOURNAL; PURPURA; SYSTEMIC DISEASE; WEAKNESS;

CRYOGLOBULINEMIA; CRYOGLOBULINS; DISEASE MANAGEMENT; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; PRACTICE GUIDELINES AS TOPIC;

EID: 79956063152     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22023     Document Type: Article

References (17)

1. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002; 55: 4-13.
2. Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006; 18: 54-63.
3. Wintrobe M, Buell M. Hyperproteinemia associated with multiple myeloma. With report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud's disease. Bull John Hopkins Hosp 1933; 52: 156-165.
4. Lerner AB, Watson CJ. Studies of cryoglobulins; unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 1947; 214: 410-415.
5. Meltzer M, Franklin EC, Elias K, et al. Cryoglobulinemia-A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837-856.
6. Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974; 57: 775-788.
7. Shihabi ZK. Cryoglobulins: An important but neglected clinical test. Ann Clin Lab Sci 2006; 36: 395-408.
8. Ferri C, La Civita L, Longombardo G, et al. Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 1993; 23: 399-405.
9. Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355-374.
10. Vermeersch P, Gijbels K, Marien G, et al. A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. Clin Chem 2008; 54: 39-43.
11. Vermeersch P, Gijbels K, Knockaert D, et al. Establishment of reference values for immunoglobulins in the cryoprecipitate. Clin Immunol 2008; 129: 360-364.
12. Zaja F, De Vita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003; 101: 3827-3834.
13. Roccatello D, Baldovino S, Rossi D, et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 2004; 19: 3054-3061.
14. Saadoun D, Resche Rigon M, Sene D, et al. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 2010; 116: 326-334; quiz 504-325.
15. Petrarca A, Rigacci L, Caini P, et al. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease. Blood 2010; 116: 335-342.
16. Wink F, Houtman PM, Jansen TL. Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: A case report and review of literature. Clin Rheumatol 2011; 30: 293-300.
17. Iannuzzella F, Vaglio A, Garini G. Management of hepatitis C virus-related mixed cryoglobulinemia. Am J Med 2010; 123: 400-408.